Unparalleled
Commitment
Meet Melinta. Visionaries striving to provide innovative therapies for acute and life-threatening illnesses.
Our Impact
We focus our expanding portfolio where patients are in need because that’s where we add the most value. And it’s only the beginning…
Our Products
Melinta provides innovative therapies for acute and life-threatening illnesses. Watch us as we grow…
We Choose Melinta
The people of Melinta are believers. Woven into the fiber of our culture is tenacity, excellence, agility, integrity and courage. We take each responsibility seriously because when we make a move, it matters.
Valued Input
At Melinta, we place a strong emphasis on speaking up. Whether that’s sharing your ideas to improve the company or relaying a customer story; we are here to listen and respond.
Talented Team
Learning opportunities come from working with talented teammates and leaders. At Melinta, we strive to build high performing teams to achieve great things. We also celebrate and reward those achievements.
Career Growth
Being at a small company provides employees with the opportunity to learn and take part in initiatives beyond their regular job. Growing your career at Melinta means having expanded responsibilities and new opportunities for growth.
Melinta News
Melinta Joins NHIA Future of Infusion Advisory Council
For Melinta, membership in the FIAC provides the opportunity for critical collaboration with the association and other organizations serving patients requiring infusion therapies. This work helps to enhance continuity of care as patients transition out of the hospital.
Melinta Therapeutics Announces IDWeek 2024 Presentations Focused on Melinta’s Portfolio of Commercial and Investigational Stage Products
Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, announced today, ten scientific presentations with data focused on Melinta’s portfolio of commercial and investigational stage products to be shared at Infectious Disease Week (IDWeek) 2024, Oct. 16-19, 2024, in Los Angeles, Californi
Melinta Therapeutics Announces the Appointment of Sunitha Lakshminarayanan, as Chief Technology Officer
Melinta Therapeutics, LLC (“Melinta”), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, announces the appointment of Sunitha Lakshminarayanan, as Chief Technology Officer, effective today.
Join a Team That’s Always Mighty!
At Melinta, you will be part of a team that is passionate and dedicated to saving lives. Our team is focused on supporting our patients and customers by delivering innovative products.